Figure 7.
GPx1 activity confers resistance to human astrocytes towards induction of vacuolization and cell death induced by (SKI+TMZ) and its expression correlates with cell's sensitivity to (SKI+TMZ) treatment. (a) Morphology of astrocytes after 48 h of treatment with (SKI+TMZ) in the presence or absence of 2.5 mM MSA. The arrow points to an exemplary cell showing vacuolization. Magnification: × 20. (b) Cell death of astrocytes after 72 h of treatment with (SKI+TMZ) in the presence or absence of 2.5 mM MSA was determined by TO-PRO staining. Results shown are the mean±S.E.M. of three independent experiments. ***P<0.001 compared with control±MSA and to (SKI+TMZ). (c) GPx1 expression in human glioblastoma cell lines and human astrocytes. Levels of 14.3.3 expression were used as a protein loading control. One experiment representative of two independent experiments is shown